Invasive neonatal Streptococcus agalactiae infection in Slovenia, 2003–2013
Abstract
Background: Streptococcus agalactiae (group B streptococcus, GBS) is the leading cause of invasive neonatal infections in the developed world. We present epidemiological and clinical characteristics of invasive GBS disease among Slovenian neonates between 2003 and 2013.
Methods: A retrospective cohort study was performed. Children aged 0–90 days with invasive GBS disease, born in Slovenia and hospitalized in the University Medical Centre Ljubljana were included. Cases were identified concurrently from (i) hospital and (ii) microbiological databases. Medical records from mothers and children were reviewed and relevant data extracted. The incidence rate was calculated based on the national vital statistics data and expressed per 1000 live births.
Results: Altogether, 144 children were included in the analysis, 72.9 % (n = 105) based on hospital database and 27.1 % (n = 39) based on microbiological database. Among them, 47.9 % (n = 69) were girls and 52.1 % (n = 75) boys. Among the cases with available data, 54.5 % (n = 73) were born at term and 45.5 % (n = 61) were preterm. Early-onset disease (0–6 days) was present in 74.3 % (n = 107) of patients; 95.3 % (n = 102) of them became ill during the first 3 days of life. Late-onset disease (7–90 days) was present in 25.7 % (n = 37) of patients. Outcome data was available for 134 children. Neonatal mortality rate was 4.5 % (n = 6). Periventricular leukomalacia (PVL) or intraventricular haemorrhages Grade III/IV (IVH 3/4) were detected in 17.9 % (n = 24). Severe outcomes (death or PVL or IVH 3/4) were detected in 22.4 % (n = 30) children. Cumulative incidence rate was 0.72/1000 live births; 0.53/1000 for early-onset and 0.18/1000 for late-onset disease. Risk factors for early-onset disease were present in 47.9 % (n = 68) mothers in labour. Intrapartum antibiotic prophylaxis was delivered to 16.9 % (n = 24) of mothers.
Conclusions: High incidence of invasive neonatal GBS disease was detected in Slovenia. Although low mortality was observed, brain pathology concordant with long-term adverse outcome was confirmed in a high proportion of patients. The application of intrapartum antibiotic prophylaxis in cases of known risk factors was suboptimal, especially among preterm deliveries. Approximately half of the patients were born to mothers without any risk factors. A comprehensive national strategy for the prevention of invasive GBS disease is warranted in Slovenia.
Downloads
References
Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010 Nov;59 RR-10:1–36. PMID:21088663
Larsen JW, Sever JL. Group B Streptococcus and pregnancy: a review. Am J Obstet Gynecol. 2008 Apr;198(4):440–8. https://doi.org/10.1016/j.ajog.2007.11.030 PMID:18201679
Guilbert J, Levy C, Cohen R, Delacourt C, Renolleau S, Flamant C; Bacterial meningitis group. Late and ultra late onset Streptococcus B meningitis: clinical and bacteriological data over 6 years in France. Acta Paediatr. 2010 Jan;99(1):47–51. https://doi.org/10.1111/j.1651–2227.2009.01510.x PMID:20002014
Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012 Feb;379(9815):547–56. https://doi.org/10.1016/S0140–6736(11)61651–6 PMID:22226047
Kwatra G, Cunnington MC, Merrall E, Adrian PV, Ip M, Klugman KP, et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016 Sep;16(9):1076–84. https://doi.org/10.1016/S1473–3099(16)30055-X PMID:27236858
Lučovnik M, Tul Mandić N, Krivec JL, Kolenc U, Jeverica S. Prevalenca kolonizacije z bakterijo Streptococcus agalactiae pri nosečnicah v Sloveniji v obdobju 2013–2014. Zdrav Vestn. 2016;85:393–400.
Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986 Jun;314(26):1665–9. https://doi.org/10.1056/NEJM198606263142603 PMID:3520319
Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012 Jul;130(1):e8–15. https://doi.org/10.1542/peds.2011–3453 PMID:22689869
Yow MD, Mason EO, Leeds LJ, Tompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA. 1979 Mar;241(12):1245–7. https://doi.org/10.1001/jama.1979.03290380021019 PMID:368363
de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998 Jan;91(1):112–4. https://doi.org/10.1016/S0029–7844(97)00587–5 PMID:9464732
Schrag SJ, Zell ER, Lynfeld R, Roome A, Arnold KE, Craig AS, et al.; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002 Jul;347(4):233–9. https://doi.org/10.1056/NEJMoa020205 PMID:12140298
Van Dyke MK, Phares CR, Lynfeld R, Tomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009 Jun;360(25):2626–36. https://doi.org/10.1056/NEJMoa0806820 PMID:19535801
Krivec JL, Jeverica S, Müller-Premru M, Arnež M. Racionalna uporaba antibiotikov v neonatologiji. In: Paro Panjan D, Kržan M, ed. Neonatalna farmakologija. Poglavja iz neonatologije. 2009;2:85–101.
Krivec JL, Mueller-Premru M, Jeverica S. Izbira antibiotikov in novosti pri zdravljenju neonatalne sepse. In: Paro Panjan D, ed. Neonatalne okužbe in imunski odziv pri novorojenčkih. Poglavja iz neonatologije. 2013;5:43–59.
Navodilo o spremembah in dopolnitvah navodila za izvajanje preventivnega zdravstvenega varstva na primarni ravni. Ur.l. RS, št. 33/2002–1.2.2. Preventivni pregledi v nosečnosti [8.10.2016]. Available from: http://www.uradni-list.si/1/objava.jsp?urlid=200233&stevilka=1391
Mednarodna klasifkacija bolezni in sorodnih zdravstvenih problemov za statisične namene, Avstralska modifkacija (MKB-10-AM). Pregledni seznam bolezni. 6.izd [6.10.2016]. Available from: http://www.nijz.si/sites/www.nijz.si/fles/uploaded/podatki/klasifkacije_sifranti/mkb/ks_mkb10-am-v6_v02_splet.pdf
Bekker V, Bijlsma MW, van de Beek D, Kuijpers TW, van der Ende A. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis. 2014 Nov;14(11):1083–9. https://doi.org/10.1016/S1473–3099(14)70919–3 PMID:25444407
Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014 Jan;27(1):21–47. https://doi.org/10.1128/CMR.00031–13 PMID:24396135
Klinger G, Levy I, Sirota L, Boyko V, Lerner-Geva L, Reichman B; Israel Neonatal Network. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics. 2010 Apr;125(4):e736–40. https://doi.org/10.1542/peds.2009–2017 PMID:20231184
Verani JR, Spina NL, Lynfeld R, Schaffner W, Harrison LH, Holst A, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol. 2014 Apr;123(4):828–37. https://doi.org/10.1097/AOG.0000000000000163 PMID:24785612
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
